Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Breast Neoplasms 5Carcinoma, Hepatocellular 4Neoplasms 2Lung Neoplasms 2Liver Neoplasms 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Liver Diseases 1Hepatitis 1Glioblastoma 1Gastrointestinal Neoplasms 1Fibrosis 1Carcinoma, Squamous Cell 1Breast Neoplasms, Male 1

Interventions

Magnetic Resonance Spectroscopy 5Pentoxifylline 4Liver Transplantation 4Blood Specimen Collection 4Specimen Handling 3High-Energy Shock Waves 3Tocopherols 2Sorafenib 2Simvastatin 2Low-Level Light Therapy 2Gemcitabine 2tremelimumab 1sonidegib 1sofosbuvir-velpatasvir drug combination 1ruxolitinib 1navitoclax 1maltodextrin 1esmolol 1epigallocatechin gallate 1durvalumab 1contrast agent BR1 1bavituximab 1atezolizumab 1apixaban 1alpha-Tocopherol 1Viusid 1Vitamin E 1Vitamin D 1Tenofovir 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Fibrosis × bavituximab × Clear all
NCT01264705 2020-11-12

Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer

University of Texas Southwestern Medical Center

Phase 1/2 Completed
47 enrolled 10 charts
Gastrointestinal

Fibrosis, Gastrointestinal Neoplasms, Hepatitis, Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡